Theratechnologies inc.
TSX : TH

Theratechnologies inc.

May 29, 2006 08:20 ET

Theratechnologies to Present at Canaccord Adams Life Sciences Mini-Conference in Montreal

MONTREAL, QUEBEC--(CCNMatthews - May 29, 2006) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer of the Company, will present a corporate update at Canaccord Adams Life Sciences Mini-Conference, which will take place this week at the University Club in Montreal. Mr. Rosconi will be speaking at 11:30 a.m., on Wednesday, May 31st.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers or acquires novel therapeutic products for development and commercialization. These products target unmet medical needs in commercially attractive specialty markets. The most advanced program is in Phase 3 clinical development in HIV-associated lipodystrophy. The Company also has other promising projects at various stages of development.

Contact Information

  • Theratechnologies inc.
    Tobie Trudel
    Director, Investor Relations and communications
    (514) 336-4804, ext. 229
    ttrudel@theratech.com